EP-1339: Feasibility and efficacy of moderately hypofractionated radiotherapy in high risk prostate cancer. (May 2017) - Marvaso, G.; Riva, G.; Bassi, C.; Fodor, C.; Ciardo, D.; Zerini, D.; Timon, G.; Surgo, A.; Maucieri, A.; Pansini, F.; De Marco, P.; Cattani, F.; et al.